Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sharon D Solomon

Showing results (41-50 of 50) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 50 results.
Retina (Philadelphia, Pa.)|February 2, 2023
DEFINING "STRONG" VERSUS "WEAK" RESPONSE TO ANTIVASCULAR ENDOTHELIAL GROWTH FACTOR TREATMENT FOR CENTER-INVOLVED DIABETIC MACULAR EDEMAJennifer K Sun, Wesley T Beaulieu, Michele Melia, et al.
BMC Ophthalmology|February 1, 2015
Evaluation of real-world mobility in age-related macular degenerationSabyasachi Sengupta, Angeline M Nguyen, Suzanne W van Landingham, et al.
Proceedings of Spie--The International Society for Optical Engineering|May 21, 2016
Voxel Based Morphometry in Optical Coherence Tomography: Validation & Core FindingsBhavna J Antony, Min Chen, Aaron Carass, et al.
JAMA Ophthalmology|January 25, 2019
Factors Associated With Visual Acuity and Central Subfield Thickness Changes When Treating Diabetic Macular Edema With Anti-Vascular Endothelial Growth Factor Therapy: An Exploratory Analysis of the Protocol T Randomized Clinical TrialSusan B Bressler, Isoken Odia, Maureen G Maguire, et al.
Ophthalmology|July 16, 2010
Antagonism of vascular endothelial growth factor for macular edema caused by retinal vein occlusions: two-year outcomesPeter A Campochiaro, Gulnar Hafiz, Roomasa Channa, et al.
Ophthalmology|February 3, 2012
Detection of new-onset choroidal neovascularization using optical coherence tomography: the AMD DOC StudyDiana V Do, Emily W Gower, Sandra D Cassard, et al.
American Journal of Ophthalmology|March 3, 2018
Shortest Distance From Fovea to Subfoveal Hemorrhage Border Is Important in Patients With Neovascular Age-related Macular DegenerationSaleema Kherani, Adrienne W Scott, Adam S Wenick, et al.
American Journal of Ophthalmology|April 8, 2019
Loss of Peak Vision in Retinal Vein Occlusion Patients Treated for Macular EdemaMustafa Iftikhar, Tahreem A Mir, Gulnar Hafiz, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 26, 2008
Ranibizumab for macular edema due to retinal vein occlusions: implication of VEGF as a critical stimulatorPeter A Campochiaro, Gulnar Hafiz, Syed Mahmood Shah, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|April 11, 2007
Comparison of the modified Early Treatment Diabetic Retinopathy Study and mild macular grid laser photocoagulation strategies for diabetic macular edema, Donald S Fong, Samara F Strauber, et al.
Pageof 5

Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
Retina (Philadelphia, Pa.)|February 2, 2023
DEFINING "STRONG" VERSUS "WEAK" RESPONSE TO ANTIVASCULAR ENDOTHELIAL GROWTH FACTOR TREATMENT FOR CENTER-INVOLVED DIABETIC MACULAR EDEMAJennifer K Sun, Wesley T Beaulieu, Michele Melia, et al.
BMC Ophthalmology|February 1, 2015
Evaluation of real-world mobility in age-related macular degenerationSabyasachi Sengupta, Angeline M Nguyen, Suzanne W van Landingham, et al.
Proceedings of Spie--The International Society for Optical Engineering|May 21, 2016
Voxel Based Morphometry in Optical Coherence Tomography: Validation & Core FindingsBhavna J Antony, Min Chen, Aaron Carass, et al.
JAMA Ophthalmology|January 25, 2019
Factors Associated With Visual Acuity and Central Subfield Thickness Changes When Treating Diabetic Macular Edema With Anti-Vascular Endothelial Growth Factor Therapy: An Exploratory Analysis of the Protocol T Randomized Clinical TrialSusan B Bressler, Isoken Odia, Maureen G Maguire, et al.
Ophthalmology|July 16, 2010
Antagonism of vascular endothelial growth factor for macular edema caused by retinal vein occlusions: two-year outcomesPeter A Campochiaro, Gulnar Hafiz, Roomasa Channa, et al.
Ophthalmology|February 3, 2012
Detection of new-onset choroidal neovascularization using optical coherence tomography: the AMD DOC StudyDiana V Do, Emily W Gower, Sandra D Cassard, et al.
American Journal of Ophthalmology|March 3, 2018
Shortest Distance From Fovea to Subfoveal Hemorrhage Border Is Important in Patients With Neovascular Age-related Macular DegenerationSaleema Kherani, Adrienne W Scott, Adam S Wenick, et al.
American Journal of Ophthalmology|April 8, 2019
Loss of Peak Vision in Retinal Vein Occlusion Patients Treated for Macular EdemaMustafa Iftikhar, Tahreem A Mir, Gulnar Hafiz, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 26, 2008
Ranibizumab for macular edema due to retinal vein occlusions: implication of VEGF as a critical stimulatorPeter A Campochiaro, Gulnar Hafiz, Syed Mahmood Shah, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|April 11, 2007
Comparison of the modified Early Treatment Diabetic Retinopathy Study and mild macular grid laser photocoagulation strategies for diabetic macular edema, Donald S Fong, Samara F Strauber, et al.
Pageof 5